Matches in Wikidata for { <http://www.wikidata.org/entity/Q62105053> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q62105053 description "clinical trial" @default.
- Q62105053 description "ensayu clínicu" @default.
- Q62105053 description "klinisch onderzoek" @default.
- Q62105053 description "клінічне випробування" @default.
- Q62105053 description "临床试验" @default.
- Q62105053 name "A Study to Examine the Effects of an Experimental Drug on Postmenopausal Osteoporosis (MK-0822-004)" @default.
- Q62105053 type Item @default.
- Q62105053 label "A Study to Examine the Effects of an Experimental Drug on Postmenopausal Osteoporosis (MK-0822-004)" @default.
- Q62105053 prefLabel "A Study to Examine the Effects of an Experimental Drug on Postmenopausal Osteoporosis (MK-0822-004)" @default.
- Q62105053 P1050 Q62105053-26359352-2B72-4D55-A4B0-67BB64152943 @default.
- Q62105053 P1132 Q62105053-202476F2-2B91-4DBC-B993-343F7CF141D4 @default.
- Q62105053 P1476 Q62105053-9E78C412-D284-42F4-AC6F-1E8F3AF09517 @default.
- Q62105053 P3098 Q62105053-E56B35A5-7C42-46D0-8B5A-B95B74B92550 @default.
- Q62105053 P31 Q62105053-8F188F58-0DFF-495D-A53F-D3230545042C @default.
- Q62105053 P4844 Q62105053-5FD8582B-65E5-4071-A86B-6F848CF84765 @default.
- Q62105053 P4844 Q62105053-7EBB1FF7-BABA-4E8A-993E-A089B5CFE191 @default.
- Q62105053 P4844 Q62105053-9376E1A7-2AB4-4EE3-85F0-993FDDD79170 @default.
- Q62105053 P580 Q62105053-FEF9F453-074C-4685-ABCC-58CE2B553340 @default.
- Q62105053 P582 Q62105053-B545F8BB-990E-4CD7-9556-A934F9083472 @default.
- Q62105053 P6099 Q62105053-0302DADD-FDD7-464C-B006-582C694FDD73 @default.
- Q62105053 P8005 Q62105053-261EA9CA-3C71-4DEE-93A8-A9A42D6A0230 @default.
- Q62105053 P8363 Q62105053-8D180CEC-F10E-4F44-BCDB-4D2661C0BBEB @default.
- Q62105053 P859 Q62105053-41E8153B-3B8A-43BA-B5D9-935CA9AA1C6A @default.
- Q62105053 P1050 Q165328 @default.
- Q62105053 P1132 "+399" @default.
- Q62105053 P1476 "A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, and Efficacy of MK-0822 (Cathepsin K Inhibitor) in the Treatment of Postmenopausal Women With Osteoporosis" @default.
- Q62105053 P3098 "NCT00112437" @default.
- Q62105053 P31 Q30612 @default.
- Q62105053 P4844 Q139347 @default.
- Q62105053 P4844 Q23767 @default.
- Q62105053 P4844 Q27161510 @default.
- Q62105053 P580 "2005-06-24T00:00:00Z" @default.
- Q62105053 P582 "2007-12-26T00:00:00Z" @default.
- Q62105053 P6099 Q42824440 @default.
- Q62105053 P8005 Q76651189 @default.
- Q62105053 P8363 Q78089383 @default.
- Q62105053 P859 Q58219685 @default.